摘要
_在过去十年中,炎症性肠病(IBD)的治疗策略和治疗方案发生了很大变化。 除了治疗方案的这种转变,还有机会根据患者的个人情况和偏好个性化治疗决策。 IBD治疗最重要的方面之一是治疗相关风险,并且有机会通过优化个体患者的药物安全性来个性化治疗。 在这篇综述中,我们讨论IBD治疗的潜在风险,缓解这些风险的机会以及在临床实践中使用这些药物时需要考虑的个性化方法。
关键词: 克罗恩氏病,溃疡性结肠炎,风险,不良事件,炎症性肠病,感染。
图形摘要
Current Drug Targets
Title:Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach
Volume: 19 Issue: 7
关键词: 克罗恩氏病,溃疡性结肠炎,风险,不良事件,炎症性肠病,感染。
摘要: Treatment strategies and treatment options have changed considerably over the past decade for Inflammatory Bowel Disease (IBD). Alongside this shift in therapeutic options has come an opportunity to personalize treatment decisions based on individual patient profiles and preferences. One of the most important aspects of therapy in IBD is treatment related risk, and an opportunity exists to personalize therapy through optimization of drug safety profiles in individual patients. In this review we discuss the potential risks of therapy in IBD, opportunities to mitigate those risks, and a personalized approach to consider when using these agents in clinical practice.
Export Options
About this article
Cite this article as:
Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach, Current Drug Targets 2018; 19 (7) . https://dx.doi.org/10.2174/1389450118666170525114939
DOI https://dx.doi.org/10.2174/1389450118666170525114939 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Molecule Approaches Toward the Non-Microbicidal Modulation of Bacterial Biofilm Growth and Maintenance
Anti-Infective Agents in Medicinal Chemistry Role of Natural Product in Modulation of Drug Transporters and New Delhi Metallo-β Lactamases
Current Topics in Medicinal Chemistry Regulating the Safety of Probiotics - The European Approach
Current Pharmaceutical Design 3-(1-Adamantylthio)-4-Phenylpyridine as a Potential Therapeutic for Methicillin-Resistant Staphylococcus aureus
Letters in Drug Design & Discovery Scintigraphic Imaging of Inflammatory Processes
Medicinal Chemistry Reviews - Online (Discontinued) Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss
Endocrine, Metabolic & Immune Disorders - Drug Targets Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets Staphylococcus aureus: Current State of Prevalence, Impact, and Vaccine Development
Current Pharmaceutical Design A Brief Overview of Antimicrobial Peptides Containing Unnatural Amino Acids and Ligand-Based Approaches for Peptide Ligands
Current Topics in Medicinal Chemistry The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
Current Respiratory Medicine Reviews Candida parapsilosis Secreted Lipase as an Important Virulence Factor
Current Protein & Peptide Science Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Update on Childhood Brucellosis
Recent Patents on Anti-Infective Drug Discovery Long-term Results After Transcatheter Aortic Valve Implantation: What do we Know Today?
Current Cardiology Reviews Extracellular Enzymes Production and Biofilm Formation in Rhodotorula Species
Current Enzyme Inhibition Cardiovascular Implantable Electronic Device Infections: Risk Scoring and Role of Antibiotic Envelope in Prevention
Recent Advances in Cardiovascular Drug Discovery (Discontinued) The Management of the Infected Diabetic Foot
Current Diabetes Reviews Bedside Lung Ultrasound in the Care of the Critically Ill
Current Respiratory Medicine Reviews In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets
Infectious Disorders - Drug Targets Short Term Statin Treatment Improves Survival and Differentially Regulates Macrophage-Mediated Responses to Staphylococcus aureus
Current Pharmaceutical Biotechnology